114 related articles for article (PubMed ID: 8417912)
21. Agranulocytosis associated with Maloprim.
Br Med J (Clin Res Ed); 1983 May; 286(6376):1515. PubMed ID: 6405867
[No Abstract] [Full Text] [Related]
22. Drug-induced hepatotoxicity.
Noble A; MacDonald A
N Engl J Med; 1996 Mar; 334(13):864. PubMed ID: 8596564
[No Abstract] [Full Text] [Related]
23. [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].
Buser P; Räber J
Schweiz Med Wochenschr; 1985 Aug; 115(34):1174-6. PubMed ID: 4048913
[TBL] [Abstract][Full Text] [Related]
24. Maloprim--general toxicity or idiosyncrasy?
Vergara RV
P N G Med J; 1984 Mar; 27(1):46. PubMed ID: 6595907
[No Abstract] [Full Text] [Related]
25. Dapsone-induced eosinophilic pneumonitis in a leprosy patient.
Kaur J; Khandpur S; Seith A; Khanna N
Indian J Lepr; 2005; 77(3):267-71. PubMed ID: 16353525
[TBL] [Abstract][Full Text] [Related]
26. "Black spots" in Papua New Guinea Defence Force personnel: report of 12 cases.
Talwat EN
Australas J Dermatol; 1983 Aug; 24(2):69-70. PubMed ID: 6229242
[No Abstract] [Full Text] [Related]
27. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
28. Maloprim-induced agranulocytosis and red-cell aplasia.
Nicholls MD; Concannon AJ
Med J Aust; 1982 Dec 11-25; 2(12):564-6. PubMed ID: 7162443
[No Abstract] [Full Text] [Related]
29. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
Arunthathi S; Raju S
Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
[TBL] [Abstract][Full Text] [Related]
30. Severe megaloblastic anaemia caused by maloprim.
Hughes A; Gatus BJ
J Trop Med Hyg; 1979 Jun; 82(6):120-1. PubMed ID: 501766
[No Abstract] [Full Text] [Related]
31. Susceptibility of Plasmodium falciparum in The Gambia to pyrimethamine, Maloprim and chloroquine.
Panton LJ; Tulloch S; Bradley AK; Greenwood BM
Trans R Soc Trop Med Hyg; 1985; 79(4):484-90. PubMed ID: 3909554
[TBL] [Abstract][Full Text] [Related]
32. Treatment of falciparum malaria with a single dose combination of dapsone and pyrimethamine (Maloprim).
Ponnampalam JT; Richards PN
Singapore Med J; 1983 Oct; 24(5):303-6. PubMed ID: 6367060
[No Abstract] [Full Text] [Related]
33. Efficacy of dapsone with pyrimethamine (Maloprim) for malaria prophylaxis in Maputo, Mozambique.
Pividal J; Viktinski V; Streat E; Schapira A
East Afr Med J; 1992 Jun; 69(6):303-5. PubMed ID: 1505413
[TBL] [Abstract][Full Text] [Related]
34. Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine.
Vrbova H; Gibney S; Gibson FD; Jolley D; Heywood PF; Stace J; Trenholme KR; Alpers MP
P N G Med J; 1992 Dec; 35(4):275-84. PubMed ID: 1341089
[TBL] [Abstract][Full Text] [Related]
35. [Pulmonary infiltrations with eosinophilia (pulmonary eosinophilia)].
Fischer BM; Schadmand S; Gerharz CD; Steppling H; Ferlinz R
Pneumologie; 1992 Sep; 46(9):476-83. PubMed ID: 1438127
[TBL] [Abstract][Full Text] [Related]
36. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
Svanbom M; Rombo L; Gustafsson L
Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1876. PubMed ID: 6428585
[No Abstract] [Full Text] [Related]
37. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
Alloueche A; Bailey W; Barton S; Bwika J; Chimpeni P; Falade CO; Fehintola FA; Horton J; Jaffar S; Kanyok T; Kremsner PG; Kublin JG; Lang T; Missinou MA; Mkandala C; Oduola AM; Premji Z; Robertson L; Sowunmi A; Ward SA; Winstanley PA
Lancet; 2004 Jun; 363(9424):1843-8. PubMed ID: 15183620
[TBL] [Abstract][Full Text] [Related]
38. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention.
Coleman MD
Toxicology; 2001 Apr; 162(1):53-60. PubMed ID: 11311458
[TBL] [Abstract][Full Text] [Related]
39. Maloprim malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania.
Lemnge MM; Msangeni HA; Rønn AM; Salum FM; Jakobsen PH; Mhina JI; Akida JA; Bygbjerg IC
Trans R Soc Trop Med Hyg; 1997; 91(1):68-73. PubMed ID: 9093633
[TBL] [Abstract][Full Text] [Related]
40. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
